These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5531310)

  • 21. Antithrombotic effects of 3-([1:1',2':1"]-3'-terphenyl)propanol in animals.
    Hongou K; Miyamae T; Hashizume H; Oshima K; Ogawa T; Hongou T; Morikawa T; Hagiwara M
    Arzneimittelforschung; 1997 Oct; 47(10):1104-8. PubMed ID: 9368702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates.
    Zhou YJ; Xiang JZ; Yuan H; Liu H; Tang Q; Hao HZ; Yin Z; Wang J; Ming ZY
    Thromb Res; 2013 Aug; 132(2):202-10. PubMed ID: 23773522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of Hageman factor and initiation of hepatic vein thrombosis in the hyperlipemic rat.
    Latour JG; Léger C; Renaud S
    Am J Pathol; 1974 Aug; 76(2):179-94. PubMed ID: 4843381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of acetyl salicylic acid therapy on an experimental thrombosis induced by laser beam.
    Aguejouf O; Malfatti E; Belon P; Doutremepuich C
    Thromb Res; 2000 Sep; 99(6):595-602. PubMed ID: 10974346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the mechanisms responsible for selection of hepatic veins as target for thrombosis following injection of endotoxin in hyperlipemic rats.
    Latour JG; Léger C; Renaud S; Simard P
    Am J Pathol; 1974 Aug; 76(2):195-212. PubMed ID: 4843382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet function tests in uraemia and under acetylsalicylic acid administration.
    Schöndoft TH; Hey D
    Haemostasis; 1974; 3(3):129-36. PubMed ID: 4461414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithrombotic effect of ticlopidine on He-Ne laser-induced thrombus formation in rat mesenteric microvessels.
    Yamamoto J; Ishii I; Sasaki Y; Nagamatsu Y; Matsuda T; Ando E
    Haemostasis; 1992; 22(3):147-52. PubMed ID: 1427459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease.
    Serebruany VL; Kogushi M; Dastros-Pitei D; Flather M; Bhatt DL
    Thromb Haemost; 2009 Jul; 102(1):111-9. PubMed ID: 19572075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Open-label, randomized study of the effect of rivaroxaban with or without acetylsalicylic acid on thrombus formation in a perfusion chamber.
    Wolzt M; Gouya G; Kapiotis S; Becka M; Mueck W; Kubitza D
    Thromb Res; 2013 Aug; 132(2):240-7. PubMed ID: 23786894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimental platelet aggregation and arterial thrombosis. Effect of aspirin].
    Bousser MG; Lecrubier C
    Nouv Presse Med; 1973 Jun; 2(25):1687-92. PubMed ID: 4718537
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo.
    Herault JP; Peyrou V; Savi P; Bernat A; Herbert JM
    Thromb Haemost; 1998 Feb; 79(2):383-8. PubMed ID: 9493595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acetylsalicylic acid and the prevention of thrombosis].
    Blättler W
    Schweiz Med Wochenschr; 1973 May; 103(20):747-52. PubMed ID: 4702992
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo.
    Schulz C; Konrad I; Sauer S; Orschiedt L; Koellnberger M; Lorenz R; Walter U; Massberg S
    Thromb Haemost; 2008 Jan; 99(1):190-5. PubMed ID: 18217153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers.
    Cadroy Y; Thalamas C; Sakariassen K; Boneu B
    Thromb Res; 2005; 116(4):293-300. PubMed ID: 16038713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera.
    Panova-Noeva M; Marchetti M; Russo L; Tartari CJ; Leuzzi A; Finazzi G; Rambaldi A; ten Cate H; Falanga A
    Thromb Res; 2013 Jul; 132(1):88-93. PubMed ID: 23735588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of drugs on blood platelet characteristics].
    Zbinden G
    Schweiz Med Wochenschr; 1971 Nov; 101(46):1658-62. PubMed ID: 5140632
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of adenosine, acetylsalicylic acid, phenylbutazone and papaverine on platelet aggregation].
    Glusa E; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(3):254-62. PubMed ID: 4106017
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacological properties of the novel anti-platelet aggregating agent 4-cyano-5,5-bis(4-methoxyphenyl)-4-pentenoic acid.
    Fujimori T; Harada K; Saeki T; Kogushi M; Akasaka K; Yamagishi Y; Yamatsu I
    Arzneimittelforschung; 1987 Oct; 37(10):1143-8. PubMed ID: 3124862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
    Vilahur G; Casaní L; Badimon L
    Thromb Haemost; 2007 Sep; 98(3):662-9. PubMed ID: 17849057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.